ArticleScientific reports2026

KLHDC4 serves as a novel prognostic biomarker and drives tumor progression via PI3K/AKT signaling in clear cell renal cell carcinoma.

Qingjiang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.